Single or continuous injection of glial cell line-derived neurotrophic factor in the striatum induces recovery of the nigrostriatal dopaminergic system

M. Aoi; I. Date; S. Tomita; T. Ohmoto

doi:10.1080/01616412.2000.11740761

Single or continuous injection of glial cell line-derived neurotrophic factor in the striatum induces recovery of the nigrostriatal dopaminergic system

M. Aoi, I. Date, S. Tomita, T. Ohmoto

Research output: Contribution to journal › Article

17 Citations (Scopus)

Abstract

Glial cell line-derived neurotrophic factor (GDNF) is a member of the transforming growth factor β superfamily and acts as a neurotrophic factor for the nigrostriatal dopaminergic system. GDNF at a dose of 100 μg was injected stereotactically into the striatum of Sprague-Dawley rats that had been treated with intrastriatal 6-hydroxydopamine (6-OHDA) injection four weeks earlier. Immunocytochemical and behavioral analyses showed significant recovery of the nigrostriatal dopaminergic system after a single GDNF injection or continuous GDNF injection. Immunocytochemical and behavioral study showed that there was no significant difference between the results obtained from the two different injection methods. This result demonstrates the potential usefulness of GDNF for the treatment of Parkinson's disease.

Original language	English
Pages (from-to)	832-836
Number of pages	5
Journal	Neurological Research
Volume	22
Issue number	8
DOIs	https://doi.org/10.1080/01616412.2000.11740761
Publication status	Published - Jan 1 2000

Keywords

Dopamine regeneration
GDNF
Parkinsons disease

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.1080/01616412.2000.11740761

Fingerprint Dive into the research topics of 'Single or continuous injection of glial cell line-derived neurotrophic factor in the striatum induces recovery of the nigrostriatal dopaminergic system'. Together they form a unique fingerprint.

Cite this

Aoi, M., Date, I., Tomita, S., & Ohmoto, T. (2000). Single or continuous injection of glial cell line-derived neurotrophic factor in the striatum induces recovery of the nigrostriatal dopaminergic system. Neurological Research, 22(8), 832-836. https://doi.org/10.1080/01616412.2000.11740761

@article{7b32db85f6b3409a9c9171e6433d553b,

title = "Single or continuous injection of glial cell line-derived neurotrophic factor in the striatum induces recovery of the nigrostriatal dopaminergic system",

abstract = "Glial cell line-derived neurotrophic factor (GDNF) is a member of the transforming growth factor β superfamily and acts as a neurotrophic factor for the nigrostriatal dopaminergic system. GDNF at a dose of 100 μg was injected stereotactically into the striatum of Sprague-Dawley rats that had been treated with intrastriatal 6-hydroxydopamine (6-OHDA) injection four weeks earlier. Immunocytochemical and behavioral analyses showed significant recovery of the nigrostriatal dopaminergic system after a single GDNF injection or continuous GDNF injection. Immunocytochemical and behavioral study showed that there was no significant difference between the results obtained from the two different injection methods. This result demonstrates the potential usefulness of GDNF for the treatment of Parkinson's disease.",

keywords = "Dopamine regeneration, GDNF, Parkinsons disease",

author = "M. Aoi and I. Date and S. Tomita and T. Ohmoto",

year = "2000",

month = jan,

day = "1",

doi = "10.1080/01616412.2000.11740761",

language = "English",

volume = "22",

pages = "832--836",

journal = "Neurological Research",

issn = "0161-6412",

publisher = "Maney Publishing",

number = "8",

}

TY - JOUR

T1 - Single or continuous injection of glial cell line-derived neurotrophic factor in the striatum induces recovery of the nigrostriatal dopaminergic system

AU - Aoi, M.

AU - Date, I.

AU - Tomita, S.

AU - Ohmoto, T.

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Glial cell line-derived neurotrophic factor (GDNF) is a member of the transforming growth factor β superfamily and acts as a neurotrophic factor for the nigrostriatal dopaminergic system. GDNF at a dose of 100 μg was injected stereotactically into the striatum of Sprague-Dawley rats that had been treated with intrastriatal 6-hydroxydopamine (6-OHDA) injection four weeks earlier. Immunocytochemical and behavioral analyses showed significant recovery of the nigrostriatal dopaminergic system after a single GDNF injection or continuous GDNF injection. Immunocytochemical and behavioral study showed that there was no significant difference between the results obtained from the two different injection methods. This result demonstrates the potential usefulness of GDNF for the treatment of Parkinson's disease.

AB - Glial cell line-derived neurotrophic factor (GDNF) is a member of the transforming growth factor β superfamily and acts as a neurotrophic factor for the nigrostriatal dopaminergic system. GDNF at a dose of 100 μg was injected stereotactically into the striatum of Sprague-Dawley rats that had been treated with intrastriatal 6-hydroxydopamine (6-OHDA) injection four weeks earlier. Immunocytochemical and behavioral analyses showed significant recovery of the nigrostriatal dopaminergic system after a single GDNF injection or continuous GDNF injection. Immunocytochemical and behavioral study showed that there was no significant difference between the results obtained from the two different injection methods. This result demonstrates the potential usefulness of GDNF for the treatment of Parkinson's disease.

KW - Dopamine regeneration

KW - GDNF

KW - Parkinsons disease

UR - http://www.scopus.com/inward/record.url?scp=0034526219&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034526219&partnerID=8YFLogxK

U2 - 10.1080/01616412.2000.11740761

DO - 10.1080/01616412.2000.11740761

M3 - Article

C2 - 11149247

AN - SCOPUS:0034526219

VL - 22

SP - 832

EP - 836

JO - Neurological Research

JF - Neurological Research

SN - 0161-6412

IS - 8

ER -